1. Home
  2. PRSO vs ERNA Comparison

PRSO vs ERNA Comparison

Compare PRSO & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$1.01

Market Cap

9.8M

Sector

Technology

ML Signal

HOLD

Logo Eterna Therapeutics Inc.

ERNA

Eterna Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
ERNA
Founded
2008
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8M
10.0M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PRSO
ERNA
Price
$1.01
$1.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
271.1K
41.4K
Earning Date
11-10-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,001,000.00
$1,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$35.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$0.52
$1.09
52 Week High
$2.37
$14.40

Technical Indicators

Market Signals
Indicator
PRSO
ERNA
Relative Strength Index (RSI) 49.71 44.27
Support Level $0.94 $1.22
Resistance Level $1.01 $1.31
Average True Range (ATR) 0.08 0.10
MACD 0.01 -0.01
Stochastic Oscillator 40.00 12.90

Price Performance

Historical Comparison
PRSO
ERNA

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Share on Social Networks: